Related Experiment Video
Updated: Jul 18, 2026

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
Anaplasmosis: focusing on host-vector-pathogen interactions for vaccine development.
José de la Fuente1, Patricia Ayoubi, Edmour F Blouin
1Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74078, USA. jose_delafuente@yahoo.com
Developing effective vaccines against Anaplasma is crucial for controlling bovine and human anaplasmosis. This study identified potential vaccine antigens targeting pathogen transmission by ticks and host-pathogen interactions.
Area of Science:
- Veterinary Parasitology
- Molecular Biology
- Immunology
Background:
- Anaplasma marginale and A. phagocytophilum cause significant animal and human diseases.
- Current vaccines for anaplasmosis are ineffective, necessitating novel control strategies.
- Controlling tick-borne transmission is a key goal for anaplasmosis vaccines.
Purpose of the Study:
- To identify and characterize host-tick-Anaplasma interactions for novel vaccine antigen discovery.
- To find antigens that can reduce Anaplasma infection and transmission by ticks.
- To discover antigens that confer protection against tick infestations.
Main Methods:
- Characterized Anaplasma marginale adhesins involved in infection and transmission.
- Performed global gene expression analysis in human cells infected with A. phagocytophilum.
- Screened for tick-protective antigens using expression library immunization and RNA interference in ticks.
Main Results:
- Identified A. marginale MSP1a as an adhesin for erythrocytes and tick cells, a potential vaccine candidate.
- Discovered key molecules involved in A. phagocytophilum infection and multiplication in human cells.
- Found vaccine candidates that reduced tick infestation, molting, oviposition, and Anaplasma infection levels.
Conclusions:
- Characterization of Anaplasma adhesins and host-pathogen interactions provides new vaccine targets.
- Novel vaccine candidates targeting tick-Anaplasma interactions show promise for controlling anaplasmosis.
- Further research into these identified antigens could lead to effective anaplasmosis control strategies.
Related Concept Videos
Malaria
Arboviral Encephalitis
Toxoplasmosis
Diversity of Protists II

